financetom
Business
financetom
/
Business
/
Omnicom Q2 revenue, adjusted EPS beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Omnicom Q2 revenue, adjusted EPS beats estimates
Jul 15, 2025 1:44 PM

Overview

* Omnicom ( OMC ) Q2 revenue rises 4.2% to $4.0 bln, beating expectations, per LSEG data

* Adjusted EPS for Q2 beats estimates at $2.05, per LSEG data

* Operating profit missed expectations, affected by acquisition and repositioning costs

Outlook

* Omnicom ( OMC ) sees significant growth opportunities from Interpublic acquisition.

* Company acknowledges macroeconomic and geopolitical uncertainties impacting business.

* Omnicom ( OMC ) cleared U.S. antitrust review for Interpublic acquisition.

Result Drivers

* ORGANIC GROWTH - Omnicom ( OMC ) achieved 3.0% organic revenue growth, driven by Media & Advertising and Precision Marketing, despite declines in Public Relations and Healthcare

* ACQUISITION COSTS - Operating profit impacted by $66 million in acquisition costs related to Interpublic merger

* REPOSITIONING EXPENSES - $88.8 million in repositioning costs, primarily for severance, affected operating income

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $4.02 $3.96

Revenue bln bln (5

Analysts

)

Q2 Beat $2.05 $2 (6

Adjusted Analysts

EPS )

Q2 EPS $1.31

Q2 Net $257.60

Income mln

Q2 Miss $439.20 $574.50

Operatin mln mln (5

g profit Analysts

)

Q2 10.9%

Operatin

g profit

Margin

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the advertising & marketing peer group is "buy"

* Wall Street's median 12-month price target for Omnicom Group Inc ( OMC ) is $99.00, about 26.6% above its July 14 closing price of $72.65

* The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients
Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients
Oct 13, 2025
Moderna Inc ( MRNA ). announced on Sunday that its clinical, safety, and translational data from its Phase 1/2 study evaluating mRNA-4359 in combination with pembrolizumab in patients with checkpoint inhibitor-resistant/refractory (CPI-R/R) melanoma will be presented at the 2025 European Society for Medical Oncology Congress. mRNA-4359 is an investigational immune-evasion targeted cancer antigen therapy (CAT) that encodes epitopes of two...
Apyx Medical Seeks Clearance for Ayon System Label Expansion
Apyx Medical Seeks Clearance for Ayon System Label Expansion
Oct 13, 2025
10:47 AM EDT, 10/13/2025 (MT Newswires) -- Apyx Medical ( APYX ) said Monday it has submitted a new premarket notification to the US Food and Drug Administration for the label expansion of its Ayon Body Contouring System to include power liposuction. Apyx said getting market clearance for power liposuction would solidify Ayon's position as an integrated body contouring system,...
Texas Instruments is Facing Tariff Headwinds to Demand Improvement, BofA Says
Texas Instruments is Facing Tariff Headwinds to Demand Improvement, BofA Says
Oct 13, 2025
10:52 AM EDT, 10/13/2025 (MT Newswires) -- Texas Instruments ( TXN ) has high-quality assets, but near- and medium-term demand improvement in the industrial economy could be dampened due to global tariffs, BofA Securities said in a Monday research report. The company also has limited exposure to the artificial intelligence capital expenditure cycle and has a rich valuation despite relatively...
SEALSQ Joins Forces With Landis+Gyr To Secure North America's Energy Grid
SEALSQ Joins Forces With Landis+Gyr To Secure North America's Energy Grid
Oct 13, 2025
SEALSQ Corp ( LAES ) and Landis+Gyr ( LGYRF ) are expanding their partnership to strengthen cybersecurity in North America’s energy infrastructure. Landis+Gyr ( LGYRF ) will implement SEALSQ’s IneS Public Key Infrastructure (PKI) solution in its electric and gas meter manufacturing facilities to enhance device authentication and data protection. The collaboration builds on earlier projects in Asia and Europe,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved